Research & Development

In the high-stakes world of biopharmaceutical development, the line between a groundbreaking success and a costly failure is often defined by the unforgiving logic of statistical significance, a reality Nektar Therapeutics recently confronted with its autoimmune drug, rezpegaldesleukin. The company

For individuals born with the rare and debilitating genetic disorder Wiskott-Aldrich syndrome, the hope for a cure has long been shadowed by the immense challenge of finding a perfectly matched stem cell donor. This condition, which severely compromises the immune system and blood clotting, leaves

A landmark investigation into the intestinal microbiome has uncovered a remarkably specific and nuanced connection to the progression of multiple sclerosis (MS), revolving around a deceptive cellular mechanism known as "molecular mimicry." Collaborative research from the University of Basel and the

We're joined today by Ivan Kairatov, a leading biopharma expert whose work is at the forefront of understanding our complex relationship with the microscopic world inside us. His team's recent discoveries are reshaping how we view the common fungus Candida albicans —not just as a potential threat,

The intricate challenge of moving living, three-dimensional biological structures across countries and continents without compromising their integrity has long been a significant barrier to advancing global biomedical research. The development of non-cryogenic transport solutions represents a

A comprehensive global study has brought to light the profound and deeply concerning disparities in survival rates among children diagnosed with cancer, revealing a stark divide that correlates directly with a country's socioeconomic development. The research, which aggregates data from numerous